Benjamin G. Bitler
Impact in
- Cancer Research top 2%
- Oncology top 2%
- PARP inhibition in cancer therapy
Papers in
-
- Epigenetics and DNA Methylation 11
- Chromatin Remodeling and Cancer 10
- RNA modifications and cancer 8
- Single-cell and spatial transcriptomics 7
- Oncology 24
- PARP inhibition in cancer therapy 13
- Co-authors
- Rugang Zhang (22 shared papers)Andrew V. Kossenkov (11 shared papers)Katherine M. Aird (10 shared papers)José R. Conejo-García (7 shared papers)Kian Behbakht (26 shared papers)David W. Speicher (9 shared papers)Joyce A. Schroeder (6 shared papers)Zachary L. Watson (14 shared papers)
- Journals
- Molecular Cancer Research (8 papers)Gynecologic Oncology (7 papers)Molecular Carcinogenesis (5 papers)Cell Reports (5 papers)Cancer Research (5 papers)
- Partner nations
- United StatesRussiaMexico
In The Last Decade
Benjamin G. Bitler
98 papers receiving 4.0k citations
Benjamin G. Bitler's Hit Papers
Peers
Comparison fields: 5 of 112
- Cancer Research 684
- Oncology 993
- Molecular Biology 2.6k
- Reproductive Medicine 299
- Pathology and Forensic Medicine 387
Countries citing papers authored by Benjamin G. Bitler
This map shows the geographic impact of Benjamin G. Bitler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin G. Bitler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin G. Bitler more than expected).
Fields of papers citing papers by Benjamin G. Bitler
This network shows the impact of papers produced by Benjamin G. Bitler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin G. Bitler. The network helps show where Benjamin G. Bitler may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin G. Bitler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers Hit paper breakdown → | 2015 | 502 |
| 2 | 2016 | 349 | |
| 3 | 2013 | 216 | |
| 4 | 2017 | 174 | |
| 5 | 2017 | 160 | |
| 6 | 2017 | 135 | |
| 7 | 2016 | 133 | |
| 8 | 2016 | 117 | |
| 9 | 2006 | 106 | |
| 10 | 2018 | 101 | |
| 11 | 2010 | 97 | |
| 12 | 2020 | 90 | |
| 13 | 2011 | 85 | |
| 14 | 2018 | 80 | |
| 15 | 2018 | 77 | |
| 16 | 2006 | 76 | |
| 17 | 2019 | 75 | |
| 18 | 2011 | 74 | |
| 19 | 2019 | 68 | |
| 20 | 2018 | 64 |
About Benjamin G. Bitler
Benjamin G. Bitler is a scholar working on Molecular Biology, Oncology, Cancer Research, Reproductive Medicine and Pathology and Forensic Medicine, having authored 103 papers that have together received 4.0k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (14 papers), PARP inhibition in cancer therapy (13 papers), Epigenetics and DNA Methylation (11 papers), Chromatin Remodeling and Cancer (10 papers), Cancer Mechanisms and Therapy (9 papers), Cancer-related molecular mechanisms research (8 papers), RNA modifications and cancer (8 papers) and Single-cell and spatial transcriptomics (7 papers). The work is most often cited by research in Cancer Research (684 citations), Oncology (993 citations), Molecular Biology (2.6k citations), Reproductive Medicine (299 citations) and Pathology and Forensic Medicine (387 citations). Benjamin G. Bitler has collaborated with scholars based in United States, Russia and Mexico. Frequent co-authors include Rugang Zhang, Andrew V. Kossenkov, Katherine M. Aird, José R. Conejo-García, Kian Behbakht, David W. Speicher, Joyce A. Schroeder, Zachary L. Watson, Azat Garipov and Hengrui Zhu. Their work appears in journals such as Molecular Cancer Research, Gynecologic Oncology, Molecular Carcinogenesis, Cell Reports and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.